Landos Biopharma Publishes Results of NX-13 Phase 1b Study i

Landos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn's and Colitis

Landos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn's and Colitis

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Bram Verstockt , John Mullaly , Landos Biopharma , Rebecca Mosig , Fabio Cataldi , Nasdaq , Exchange Commission , Landos Biopharma Inc , Lifesci Advisors , Corporate Development , Biopharma Publishes Results , Ulcerative Colitis , Well Tolerated , Demonstrated Early Signs , Rapid Symptomatic Relief , Endoscopic Improvement , Concept Study , Top Line Readout , Executive Vice President , Chief Medical Officer , Clinical Efficacy , Active Ulcerative Colitis , Annual Reports , Quarterly Reports , Vice President , Sci Advisors ,